Citius Oncology (CTOR) Ending Cash Balance (2022 - 2026)
Citius Oncology (CTOR) posted Ending Cash Balance of $16.56 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $112.00 a year earlier and up 529.2% from the prior quarter.
Powered by 
Analysis
Citius Oncology (CTOR) Ending Cash Balance (2022 - 2026) Analysis & Trends
For FY2025 (ended Sep 30, 2025), Citius Oncology's Ending Cash Balance came in at $3.92 million.
- Annual Ending Cash Balance shows a three-year compound annual growth rate of 138.5% (FY2022 to FY2025).
- In prior fiscal years, Citius Oncology's Ending Cash Balance was $112.00 in FY2024, $32,746 in FY2023 (-88.7%) and $289,175 in FY2022.
- The fiscal Q3 2026 figure stands as the highest quarterly Ending Cash Balance in data going back to fiscal Q4 2022.
- According to Business Quant data, Ending Cash Balance for the three prior fiscal quarters was $2.63 million (Q2 2026), $7.3 million (Q1 2026) and $3.92 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Citius Oncology | 60.42 Mn | 30.00 Mn | 1.00 Mn | 16.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.56 Mn |
| Mar 31, 2026 | 2.63 Mn |
| Dec 31, 2025 | 7.30 Mn |
| Sep 30, 2025 | 3.92 Mn |
| Jun 30, 2025 | 112.00 |
| Mar 31, 2025 | 112.00 |
| Dec 31, 2024 | 112.00 |
| Sep 30, 2024 | 112.00 |
| Jun 30, 2024 | 261.00 |
| Mar 31, 2024 | 33,330.00 |
| Dec 31, 2023 | 32,746.00 |
| Sep 30, 2023 | 26,523.00 |
| Jun 30, 2023 | 370,095.00 |
| Mar 31, 2023 | 120,376.00 |
| Dec 31, 2022 | 289,175.00 |
API Access
Citius Oncology Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CTOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();